Early Treatment with Atorvastatin in Patientswith Acute Coronary Syndrome
GUO Hai-peng,TANG Qi-zhu,MA Min-min,ZHANG Yu
DOI: https://doi.org/10.3969/j.issn.1004-7115.2006.07.006
2006-01-01
Abstract:Objective:To observe the effects of atorvastatin on hight sensitivity C-reactive protein(hs-CRP),matrix metalloproteinase-9(MMP-9),blood lipid and cardiovascular events in patients with acute coronary syndrome(ACS) in early stage.Method: The 103 ACS patients were randomly divided into routine treatment control group(n=48) and treatment group(n= 55) with added atorvastatin 10 mg per day with 48 h from onset.The levels of TC,LDLC,HDL-C,TG,hs-CRP,and MMP-9 before and after two and four week treatmet and major cardiovascular events in 6 months were observed.Results:After two weeks treatment with atorvastain 10 mg per day,the levels of hs-CRP and MMP-9 decreased significantly than per-treatment(P0.05).After 4weeks treatment,TC,LDL-C,hs-CRP and MMP-9 were all lowered significantly(P0.05),Comparing with the general treatment group,they were decreased significantly too(P0.05).There were relatively lower recurrent angina pectoris,congestive heart failure and arrhypthmia than control group during the 6 months follow up(P0.05) Conclusion: Comparing with the general treatment group,atorvastain show better effects on decreasing levels of hs-CRP and MMP-9 in early stage,stable atherosclerotic plaque and improve clinic prognosis.